cytarabine 20 mg/mL (Cytarabine INJECTION, SOLUTION) 20 mg/mL

Cytarabine 20 mg/mL is a prescription medication used for various medical conditions. This injectable solution is available in 5 mL vials, offering flexibility in administration routes.

Strength

20 mg/mL

Pack Size

5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytarabine is primarily used in the treatment of certain types of cancer, particularly leukemia. It works by interfering with the growth of cancer cells. Cytarabine 20 mg/mL is administered via intrathecal, intravenous, or subcutaneous routes, depending on the prescribed treatment plan. Patients often wonder, 'What is cytarabine used for?' and the answer lies in its role as a chemotherapy agent.

Side Effects

Common effects of cytarabine may include nausea, vomiting, and fatigue. Some patients may experience fever or chills. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized information.

Precautions & Warnings

Cytarabine should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Proper storage and disposal of cytarabine vials are crucial to ensure safety.

Avoid Interactions

Cytarabine may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how cytarabine works in the body.

Frequently Asked Questions

Cytarabine is used in the treatment of certain types of cancer, particularly leukemia. It interferes with the growth of cancer cells.

Cytarabine can be administered via intrathecal, intravenous, or subcutaneous routes, depending on the treatment plan.

Common effects may include nausea, vomiting, fatigue, and fever. These effects can vary among individuals.

Cytarabine may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Cytarabine should be stored as per the manufacturer's instructions, typically in a cool, dry place away from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.